Study on GSPT1: A Non-Coding RNA Molecule as A Potential Drug Target

Target Name: GSPT1

NCBI ID: G2935

GSPT1

Study on GSPT1: A Non-Coding RNA Molecule as A Potential Drug Target

GSPT1 (ERF3A_HUMAN), a gene that encodes a protein known as GSPT1, has been identified as a potential drug target (or biomarker) for the treatment of various diseases, including cancer, neurodegenerative disorders, and autoimmune diseases. Its functions and interactions with other genes have been extensively studied, providing a foundation for its potential use in drug development.

GSPT1 is a non-coding RNA molecule that plays a critical role in the regulation of gene expression. It is a part of a large intergenic region (IGR) that contains several well-studied gene expression clusters, including the GSPT1 gene itself and several other genes involved in the regulation of RNA stability, translation, and degradation. GSPT1 is a key regulator of these genes, and its activity has been implicated in the development and progression of various diseases.

One of the most significant functions of GSPT1 is its role in the regulation of microRNA (miRNA) expression. miRNA is a type of non-coding RNA molecules that regulate gene expression in cells and participate in a variety of biological processes, including development and cell differentiation. , cell cycle regulation, apoptosis, immune response, metabolism and signal transduction, etc. By binding to miRNA molecules, GSPT1 can regulate their stability, translation and degradation. This has important implications for the development of diseases, as disrupted miRNA regulation is often associated with the pathogenesis of various diseases.

In addition to its role in miRNA regulation, GSPT1 is also involved in the regulation of gene expression and cellular processes. For example, GSPT1 has been shown to play a role in the regulation of cell adhesion, a critical process that is involved in tissue structure and function. GSPT1 has also been shown to be involved in the regulation of cell migration, a critical process that is involved in the development and progression of cancer.

GSPT1 has also been shown to play a role in the regulation of inflammation and immune responses. GSPT1 has been shown to be involved in the regulation of the production of pro-inflammatory cytokines, such as TNF-alpha, IL-1, and IL- 6. It has also been shown to play a role in the regulation of the production of anti-inflammatory cytokines, such as IL-10 and IL-12. These cytokines are involved in the regulation of immune responses, and their production is critical for the regulation of both innate and adaptive immunity.

GSPT1 has also been shown to play a role in the regulation of cellular stress responses. GSPT1 has been shown to be involved in the regulation of the stress response pathways, including the G1/S transition and the G0/G1 transition. These pathways are important for the regulation of cellular stress responses, and are involved in the regulation of cellular processes such as DNA damage repair, cell cycle progression, and cell death.

GSPT1 has also been shown to play a role in the regulation of cellular processes that are important for the development and progression of neurodegenerative disorders. For example, GSPT1 has also been shown to play a role in the regulation of the production of neurotransmitters, such as dopamine and serotonin. These neurotransmitters are involved in the regulation of various cellular processes, including mood, appetite, and movement. GSPT1 has also been shown to play a role in the regulation of the production of synaptic proteins, which are involved in the regulation of neural communication.

In conclusion, GSPT1 is a non-coding RNA molecule that has a wide range of functions and interactions with other genes. Its regulation of miRNA expression, gene expression, cellular processes, inflammation, and immune responses, as well as its role in the regulation

Protein Name: G1 To S Phase Transition 1

Functions: Involved in translation termination in response to the termination codons UAA, UAG and UGA (By similarity). Stimulates the activity of ETF1 (By similarity). Involved in regulation of mammalian cell growth (PubMed:2511002). Component of the transient SURF complex which recruits UPF1 to stalled ribosomes in the context of nonsense-mediated decay (NMD) of mRNAs containing premature stop codons (PubMed:24486019). Required for SHFL-mediated translation termination which inhibits programmed ribosomal frameshifting (-1PRF) of mRNA from viruses and cellular genes (PubMed:30682371)

The "GSPT1 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about GSPT1 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets